Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 41 | 20 | 426 | -68 | 4,410 |
| Gross Profit | 41 | 20 | 426 | -68 | 4,410 |
| Operating Expenses | 94,530 | 103,192 | 96,355 | 87,672 | 101,324 |
| Operating Income | -94,489 | -103,172 | -95,929 | -87,740 | -96,914 |
| Interest Expense | 1,636 | 9 | 35 | 8 | 5 |
| Other Income | 7,351 | 8,122 | 7,517 | 2,838 | -171 |
| Pre-tax Income | -88,774 | -95,059 | -88,447 | -84,910 | -97,090 |
| Income Tax | -681 | N/A | N/A | -197 | N/A |
| Net Income Continuous | -88,093 | -95,059 | -88,447 | -84,713 | -97,090 |
| Net Income | $-88,093 | $-95,059 | $-88,447 | $-84,713 | $-97,090 |
| EPS Basic Total Ops | -1.00 | -1.34 | -1.66 | -1.81 | -2.35 |
| EPS Basic Continuous Ops | -1.00 | -1.34 | -1.66 | -1.81 | -2.35 |
| EPS Diluted Total Ops | -1.00 | -1.34 | -1.66 | -1.81 | -2.35 |
| EPS Diluted Continuous Ops | -1.00 | -1.34 | -1.66 | -1.81 | -2.35 |
| EPS Diluted Before Non-Recurring Items | -1.00 | -1.34 | -1.43 | -1.81 | -2.07 |
| EBITDA(a) | $-96,238 | $-106,784 | $-85,504 | $-87,945 | $-96,363 |